Drugs / SAR366234
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02531152 | Sep 2015 → Apr 2016 | open-angle glaucoma | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR366234 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02531152 ↗ |
| Route | Topical | “ascending repeated topical doses of SAR366234” NCT02531152 ↗ |